Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We? | Front Immunol | 2022 | 35359987 | PubTator, text mining | PubMed |
| Stem cell-homing hydrogel-based miR-29b-5p delivery promotes cartilage regeneration by suppressing senescence in an osteoarthritis rat model. | Sci Adv | 2022 | 35353555 | PubTator, text mining | PubMed |
| Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis. | Front Cardiovasc Med | 2022 | 35350534 | PubTator, text mining | PubMed |
| Depleted Long Noncoding RNA GAS5 Relieves Intervertebral Disc Degeneration via microRNA-17-3p/Ang-2. | Oxid Med Cell Longev | 2022 | 35340210 | PubTator, text mining | PubMed |
| Oxidative stress-induced circKIF18A downregulation impairs MCM7-mediated anti-senescence in intervertebral disc degeneration. | Exp Mol Med | 2022 | 35332256 | PubTator, text mining | PubMed |
| Effect of Dietary Polyphenols on Osteoarthritis-Molecular Mechanisms. | Life (Basel) | 2022 | 35330187 | PubTator, text mining | PubMed |
| Histone Extraction from Human Articular Cartilage for the Study of Epigenetic Regulation in Osteoarthritis. | Int J Mol Sci | 2022 | 35328777 | PubTator, text mining | PubMed |
| Pathophysiology of Atherosclerosis. | Int J Mol Sci | 2022 | 35328769 | PubTator, text mining | PubMed |
| Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach. | Int J Mol Sci | 2022 | 35328380 | PubTator, text mining | PubMed |
| First Characterization of ADAMTS-4 in Kidney Tissue and Plasma of Patients with Chronic Kidney Disease-A Potential Novel Diagnostic Indicator. | Diagnostics (Basel) | 2022 | 35328201 | PubTator, text mining | PubMed |
| Continuous Low-Intensity Ultrasound Preserves Chondrogenesis of Mesenchymal Stromal Cells in the Presence of Cytokines by Inhibiting NFκB Activation. | Biomolecules | 2022 | 35327626 | PubTator, text mining | PubMed |
| Chondroprotective Effects of 4,5-Dicaffeoylquinic Acid in Osteoarthritis through NF-κB Signaling Inhibition. | Antioxidants (Basel) | 2022 | 35326137 | PubTator, text mining | PubMed |
| Taurine attenuates ER stress‑associated apoptosis and catabolism in nucleus pulposus cells. | Mol Med Rep | 2022 | 35315493 | PubTator, text mining | PubMed |
| The Added Value of the "Co" in Co-Culture Systems in Research on Osteoarthritis Pathology and Treatment Development. | Front Bioeng Biotechnol | 2022 | 35309991 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis. | Front Cell Dev Biol | 2022 | 35309949 | PubTator, text mining | PubMed |
| The Role of IL-17-Mediated Inflammatory Processes in the Pathogenesis of Intervertebral Disc Degeneration and Herniation: A Comprehensive Review. | Front Cell Dev Biol | 2022 | 35309927 | PubTator, text mining | PubMed |
| BRD4 Inhibition Suppresses Senescence and Apoptosis of Nucleus Pulposus Cells by Inducing Autophagy during Intervertebral Disc Degeneration: An In Vitro and In Vivo Study. | Oxid Med Cell Longev | 2022 | 35308165 | PubTator, text mining | PubMed |
| The advances in nanomedicine for bone and cartilage repair. | J Nanobiotechnology | 2022 | 35303876 | PubTator, text mining | PubMed |
| Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesis. | Sci Rep | 2022 | 35288626 | PubTator, text mining | PubMed |
| TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease. | Mol Cell Proteomics | 2022 | 35283288 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=29